An Efficacy and Safety Study of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia
Clinical trial NCT00524043 · COMPLETED
Trial details
- NCT number
- NCT00524043
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2008-11-01
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.